{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:48:32Z","timestamp":1795016912716,"version":"4.10.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"InFLAMES Research Flagship"},{"name":"Cleerly inc."},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Research Council of Finland"},{"name":"Finnish State Research Funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronary artery disease (CAD) is a major contributor to cardiovascular events in individuals with diabetes. Quantification of coronary atherosclerotic burden is now feasible from coronary computed tomography angiography (CTA) whereas positron emission tomography (PET) enables quantitative assessment of myocardial perfusion. We studied the prognostic implications of quantitatively measured coronary plaque burden and myocardial perfusion in diabetic vs. non-diabetic patients with suspected CAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this observational cohort study, 1311 symptomatic patients with suspected CAD underwent coronary CTA and [\n                      <jats:sup>15<\/jats:sup>\n                      O]H\n                      <jats:sub>2<\/jats:sub>\n                      O PET perfusion imaging. Coronary plaque burden was quantified using artificial intelligence\u2013based analysis and reported as percent atheroma volume (PAV). Myocardial perfusion was assessed as regional stress myocardial blood flow (sMBF), with abnormal perfusion defined as\u2009\u2265\u20092 adjacent segments with sMBF\u2009&lt;\u20092.3\u00a0ml\/g\/min. The composite endpoint was all-cause death, myocardial infarction (MI), or unstable angina pectoris (UAP) over 7\u00a0years.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 1311 patients, 251 (19%) had diabetes and 134 (10%) experienced an adverse event during follow-up. The annual event rate was low (0.8% [95% CI 0.6\u20131.1%]) in non-diabetic patients with normal myocardial perfusion and increased significantly with the presence of either diabetes (2.3% [95% CI 1.4\u20133.8%]), abnormal perfusion (2.6% [95% CI 2.1\u20133.3%]), or both (3.2% [95% CI 2.1\u20134.8%]) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Among patients with normal myocardial perfusion, those with diabetes had two-fold PAV as compared with non-diabetic individuals (median 8.2% vs. 4.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). In multivariable Cox regression models, both PAV (HR 1.03 [95% CI 1.01\u20131.05] per 1% increase,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and regional sMBF (HR 1.04 [95% CI 1.01\u20131.07] per 0.1\u00a0ml\/g\/min decrease,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016) were independent predictors of adverse outcome in non-diabetic patients. In diabetic patients, only PAV (HR 1.04 [95% CI 1.01\u20131.07],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014) was predictive, whereas sMBF was not.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Coronary atherosclerotic plaque burden appears as an important predictor of long-term cardiovascular outcomes both in diabetic and non-diabetic patients. In patients with diabetes, normal myocardial perfusion does not necessarily imply low event risk, partly attributable to higher coronary plaque burden. Quantitative imaging methods for detailed CAD phenotyping shed light on the complex relationship between diabetes and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-025-03006-x","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T20:24:29Z","timestamp":1764707069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic implications of quantified coronary atherosclerosis and myocardial perfusion in diabetes"],"prefix":"10.1186","volume":"24","author":[{"given":"Matias","family":"M\u00e4enp\u00e4\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruurt A.","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pepijn","family":"van Diemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"B\u00e4r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter G.","family":"Raijmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Sprengers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel S.","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J.","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Knaapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhani","family":"Knuuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Danad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Saraste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Maaniitty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"3006_CR1","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar N, Gao P, Kondapally Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(10)60484-9.","journal-title":"Lancet"},{"key":"3006_CR2","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1056\/NEJMOA1504347","volume":"373","author":"M Tancredi","year":"2015","unstructured":"Tancredi M, Rosengren A, Svensson A-M, Kosiborod M, Pivodic A, Gudbj\u00f6rnsdottir S, et al. Excess mortality among persons with type 2 diabetes. N Engl J Med. 2015;373:1720\u201332. https:\/\/doi.org\/10.1056\/NEJMOA1504347.","journal-title":"N Engl J Med"},{"key":"3006_CR3","doi-asserted-by":"publisher","unstructured":"Diabetes mellitus, fasting glucose, and risk of cause-specific death. New England Journal of Medicine [Internet]. New England Journal of Medicine (NEJM\/MMS); 2011;364:829\u201341. https:\/\/doi.org\/10.1056\/NEJMOA1008862\/SUPPL_FILE\/NEJMOA1008862_DISCLOSURES.PDF.","DOI":"10.1056\/NEJMOA1008862\/SUPPL_FILE\/NEJMOA1008862_DISCLOSURES.PDF"},{"key":"3006_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402:203\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6.","journal-title":"Lancet"},{"key":"3006_CR5","doi-asserted-by":"publisher","unstructured":"Haffner SM, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New England Journal of Medicine [Internet]. New England Journal of Medicine (NEJM\/MMS); 1998 [cited 2025 Feb 18];339:229\u201334. https:\/\/doi.org\/10.1056\/NEJM199807233390404\/ASSET\/D4D54E27-F523-4E93-A1FD-ABBA63E988B1\/ASSETS\/IMAGES\/LARGE\/NEJM199807233390404_T3.JPG.","DOI":"10.1056\/NEJM199807233390404\/ASSET\/D4D54E27-F523-4E93-A1FD-ABBA63E988B1\/ASSETS\/IMAGES\/LARGE\/NEJM199807233390404_T3.JPG"},{"issue":"2","key":"3006_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/J.1464-5491.2008.02640.X","volume":"26","author":"U Bulugahapitiya","year":"2009","unstructured":"Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med. 2009;26(2):142\u20138. https:\/\/doi.org\/10.1111\/J.1464-5491.2008.02640.X.","journal-title":"Diabet Med"},{"issue":"8","key":"3006_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2337\/DC16-2388","volume":"40","author":"KKW Olesen","year":"2017","unstructured":"Olesen KKW, Madsen M, Egholm G, Thim T, Jensen LO, Raungaard B, et al. Patients with diabetes without significant angiographic coronary artery disease have the same risk of myocardial infarction as patients without diabetes in a real-world population receiving appropriate prophylactic treatment. Diabetes Care. 2017;40(8):1103\u201310. https:\/\/doi.org\/10.2337\/DC16-2388.","journal-title":"Diabetes Care"},{"key":"3006_CR8","doi-asserted-by":"publisher","unstructured":"Olesen KKW, Group on behalf of TWDCCS, Riis AH, Group on behalf of TWDCCS, Nielsen LH, Group on behalf of TWDCCS, et al. Risk stratification by assessment of coronary artery disease using coronary computed tomography angiography in diabetes and non-diabetes patients: a study from the Western Denmark Cardiac Computed Tomography Registry. Eur Heart J Cardiovasc Imaging; 2019 [cited 2025 May 23];20:1271\u20138. https:\/\/doi.org\/10.1093\/EHJCI\/JEZ010","DOI":"10.1093\/EHJCI\/JEZ010"},{"key":"3006_CR9","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/J.JCMG.2015.12.027","volume":"9","author":"P Blanke","year":"2016","unstructured":"Blanke P, Naoum C, Ahmadi A, Cheruvu C, Soon J, Arepalli C, et al. Long-term prognostic utility of coronary CT angiography in stable patients with diabetes mellitus. JACC Cardiovasc Imaging. 2016;9:1280\u20138. https:\/\/doi.org\/10.1016\/J.JCMG.2015.12.027.","journal-title":"JACC Cardiovasc Imaging"},{"key":"3006_CR10","doi-asserted-by":"publisher","unstructured":"Wamil M, Goncalves M, Rutherford A, Borlotti A, Pellikka PA. Multi-modality cardiac imaging in the management of diabetic heart disease. Front Cardiovasc Med [Internet]. Frontiers Media SA; 2022 [cited 2024 Mar 10];9. https:\/\/doi.org\/10.3389\/FCVM.2022.1043711","DOI":"10.3389\/FCVM.2022.1043711"},{"key":"3006_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/EURHEARTJ\/EHAE177","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAE177.","journal-title":"Eur Heart J"},{"key":"3006_CR12","doi-asserted-by":"publisher","unstructured":"Virani SS, Newby LK, Arnold S V., Bittner V, Brewer LPC, Demeter SH, et al. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the management of patients with chronic coronary disease: a report of the american heart association\/American college of cardiology joint committee on clinical practice guidelines. Circulation [Internet]. Lippincott Williams and Wilkins; 2023 [cited 2025 Feb 18];148:E9\u2013119. https:\/\/doi.org\/10.1161\/CIR.0000000000001168\/SUPPL_FILE\/ONLINE.","DOI":"10.1161\/CIR.0000000000001168\/SUPPL_FILE\/ONLINE"},{"key":"3006_CR13","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1007\/S00259-020-05093-2","volume":"48","author":"E Harjulahti","year":"2021","unstructured":"Harjulahti E, Maaniitty T, Nammas W, Stenstr\u00f6m I, Biancari F, Bax JJ, et al. Global and segmental absolute stress myocardial blood flow in prediction of cardiac events: [15O] water positron emission tomography study. Eur J Nucl Med Mol Imaging. 2021;48:1434\u201344. https:\/\/doi.org\/10.1007\/S00259-020-05093-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3006_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.121.012599","volume":"15","author":"KK Patel","year":"2022","unstructured":"Patel KK, Peri-Okonny PA, Qarajeh R, Patel FS, Sperry BW, McGhie AI, et al. Prognostic relationship between coronary artery calcium score, perfusion defects, and myocardial blood flow reserve in patients with suspected coronary artery disease. Circ Cardiovasc Imaging. 2022;15:E012599. https:\/\/doi.org\/10.1161\/CIRCIMAGING.121.012599.","journal-title":"Circ Cardiovasc Imaging"},{"key":"3006_CR15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/J.AMJMED.2021.12.010","volume":"135","author":"T Alnabelsi","year":"2022","unstructured":"Alnabelsi T, Ahmed AI, Han Y, Al Rifai M, Nabi F, Cainzos-Achirica M, et al. Added prognostic value of plaque burden to computed tomography angiography and myocardial perfusion imaging in patients with diabetes. Am J Med. 2022;135:761-768.e7. https:\/\/doi.org\/10.1016\/J.AMJMED.2021.12.010.","journal-title":"Am J Med"},{"key":"3006_CR16","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/S12350-019-01846-1","volume":"27","author":"W Acampa","year":"2020","unstructured":"Acampa W, Assante R, Zampella E, Petretta M, Cuocolo A. Myocardial perfusion imaging for diabetes: key points from the evidence and clinical questions to be answered. J Nucl Cardiol. 2020;27:1569\u201377. https:\/\/doi.org\/10.1007\/S12350-019-01846-1.","journal-title":"J Nucl Cardiol"},{"key":"3006_CR17","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.112.120402","volume":"126","author":"VL Murthy","year":"2012","unstructured":"Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126:1858\u201368. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.120402.","journal-title":"Circulation"},{"key":"3006_CR18","doi-asserted-by":"publisher","unstructured":"Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, et al. 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/ SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation [Internet]. Lippincott Williams and Wilkins; 2021 [cited 2025 Feb 18];144:E368\u2013454. https:\/\/doi.org\/10.1161\/CIR.0000000000001029\/SUPPL_FILE\/DATA.","DOI":"10.1161\/CIR.0000000000001029\/SUPPL_FILE\/DATA"},{"key":"3006_CR19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/J.JCCT.2021.05.004","volume":"15","author":"AD Choi","year":"2021","unstructured":"Choi AD, Marques H, Kumar V, Griffin WF, Rahban H, Karlsberg RP, et al. CT \u200bevaluation \u200bby \u200bartificial \u200bintelligence \u200bfor \u200batherosclerosis, stenosis and vascular \u200bmorphology \u200b(CLARIFY): \u200ba \u200bmulti-center, international study. J Cardiovasc Comput Tomogr. 2021;15:470\u20136. https:\/\/doi.org\/10.1016\/J.JCCT.2021.05.004.","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"3006_CR20","doi-asserted-by":"publisher","unstructured":"Nurmohamed NS, Bom MJ, Jukema RA, de Groot RJ, Driessen RS, van Diemen PA, et al. AI-Guided Quantitative Plaque Staging Predicts Long-Term Cardiovascular Outcomes in Patients at Risk for Atherosclerotic CVD. JACC Cardiovasc Imaging. Elsevier Inc.; 2023; https:\/\/doi.org\/10.1016\/J.JCMG.2023.05.020.","DOI":"10.1016\/J.JCMG.2023.05.020"},{"key":"3006_CR21","doi-asserted-by":"publisher","unstructured":"Lehtonen E, Kujala I, Tamminen J, Maaniitty T, Saraste A, Teuho J, et al. Incremental prognostic value of downstream positron emission tomography perfusion imaging after coronary computed tomography angiography: a study using machine learning. Eur Heart J Cardiovasc Imaging [Internet]. Oxford Academic; 2024 [cited 2024 Mar 14];25:285\u201392. https:\/\/doi.org\/10.1093\/EHJCI\/JEAD246.","DOI":"10.1093\/EHJCI\/JEAD246"},{"key":"3006_CR22","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jcmg.2016.10.025","volume":"10","author":"T Maaniitty","year":"2017","unstructured":"Maaniitty T, Stenstr\u00f6m I, Bax JJ, Uusitalo V, Ukkonen H, Kajander S, et al. Prognostic value of coronary CT angiography with selective PET perfusion imaging in coronary artery disease. JACC Cardiovasc Imaging. 2017;10:1361. https:\/\/doi.org\/10.1016\/j.jcmg.2016.10.025.","journal-title":"JACC Cardiovasc Imaging"},{"key":"3006_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/EHJCI\/JEAC258","volume":"24","author":"R Jukema","year":"2023","unstructured":"Jukema R, Maaniitty T, van Diemen P, Berkhof H, Raijmakers PG, Sprengers R, et al. Warranty period of coronary computed tomography angiography and [15O]H2O positron emission tomography in symptomatic patients. Eur Heart J Cardiovasc Imaging. 2023;24:304\u201311. https:\/\/doi.org\/10.1093\/EHJCI\/JEAC258.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3006_CR24","doi-asserted-by":"publisher","unstructured":"Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J [Internet]. Oxford Academic; 2020 [cited 2022 Jun 15];41:255\u2013323. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHZ486.","DOI":"10.1093\/EURHEARTJ\/EHZ486"},{"key":"3006_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1161\/CIRCULATIONAHA.109.915009","volume":"122","author":"S Kajander","year":"2010","unstructured":"Kajander S, Joutsiniemi E, Saraste M, Pietil\u00e4 M, Ukkonen H, Saraste A, et al. Cardiac positron emission tomography\/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation. 2010;122:603\u201313. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.915009.","journal-title":"Circulation"},{"issue":"1","key":"3006_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/S00259-011-1956-0","volume":"39","author":"I Danad","year":"2012","unstructured":"Danad I, Raijmakers PG, Appelman YE, Harms HJ, De Haan S, Van Den Oever MLP, et al. Coronary risk factors and myocardial blood flow in patients evaluated for coronary artery disease: a quantitative [15O]H2O PET\/CT study. Eur J Nucl Med Mol Imaging. 2012;39(1):102\u201312. https:\/\/doi.org\/10.1007\/S00259-011-1956-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3006_CR27","doi-asserted-by":"publisher","unstructured":"B\u00e4r S, Knuuti J, Saraste A, Kl\u00e9n R, Kero T, Nabeta T, et al. Derivation and validation of an artificial intelligence-based plaque burden safety cut-off for long-term acute coronary syndrome from coronary computed tomography angiography. Eur Heart J Cardiovasc Imaging [Internet]. Oxford Academic; 2025 [cited 2025 Oct 22];26:1163\u201373. https:\/\/doi.org\/10.1093\/EHJCI\/JEAF121.","DOI":"10.1093\/EHJCI\/JEAF121"},{"key":"3006_CR28","doi-asserted-by":"publisher","unstructured":"Griffin WF, Choi AD, Riess JS, Marques H, Chang HJ, Choi JH, et al. AI Evaluation of Stenosis on Coronary CTA, Comparison With Quantitative Coronary Angiography and Fractional Flow Reserve: A CREDENCE Trial Substudy. JACC Cardiovasc Imaging. Elsevier Inc.; 2023;16:193\u2013205. https:\/\/doi.org\/10.1016\/J.JCMG.2021.10.020.","DOI":"10.1016\/J.JCMG.2021.10.020"},{"key":"3006_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/J.CLINIMAG.2022.01.016","volume":"84","author":"RA Jonas","year":"2022","unstructured":"Jonas RA, Barkovich E, Choi AD, Griffin WF, Riess J, Marques H, et al. The effect of scan and patient parameters on the diagnostic performance of AI for detecting coronary stenosis on coronary CT angiography. Clin Imaging. 2022;84:149\u201358. https:\/\/doi.org\/10.1016\/J.CLINIMAG.2022.01.016.","journal-title":"Clin Imaging"},{"key":"3006_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/OPENHRT-2024-003115","author":"R Bernardo","year":"2025","unstructured":"Bernardo R, Nurmohamed NS, Bom MJ, Jukema R, De Winter RW, Sprengers R, et al. Diagnostic accuracy in coronary CT angiography analysis: artificial intelligence versus human assessment. Open Heart. 2025. https:\/\/doi.org\/10.1136\/OPENHRT-2024-003115.","journal-title":"Open Heart"},{"issue":"5","key":"3006_CR31","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/J.JCCT.2020.01.012","volume":"14","author":"AR van Rosendael","year":"2020","unstructured":"van Rosendael AR, Lin FY, Ma X, van den Hoogen IJ, Gianni U, Al Hussein O, et al. Percent atheroma volume: optimal variable to report whole-heart atherosclerotic plaque burden with coronary CTA, the PARADIGM study. J Cardiovasc Comput Tomogr. 2020;14(5):400\u20136. https:\/\/doi.org\/10.1016\/J.JCCT.2020.01.012.","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"3006_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1161\/hc0402.102975","volume":"105","author":"MD Cerqueira","year":"2002","unstructured":"Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial sementation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539\u201342. https:\/\/doi.org\/10.1161\/hc0402.102975.","journal-title":"Circulation"},{"key":"3006_CR33","doi-asserted-by":"publisher","unstructured":"Danad I, Uusitalo V, Kero T, Saraste A, Raijmakers PG, Lammertsma AA, et al. Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [(15)O]H2O PET imaging. J Am Coll Cardiol [Internet]. J Am Coll Cardiol; 2014 [cited 2022 Nov 8];64:1464\u201375. https:\/\/doi.org\/10.1016\/J.JACC.2014.05.069.","DOI":"10.1016\/J.JACC.2014.05.069"},{"key":"3006_CR34","doi-asserted-by":"publisher","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J [Internet]. Oxford Academic; 2023 [cited 2025 May 15];44:3720\u2013826. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAD191.","DOI":"10.1093\/EURHEARTJ\/EHAD191"},{"key":"3006_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/S12933-023-01850-3","author":"M M\u00e4enp\u00e4\u00e4","year":"2023","unstructured":"M\u00e4enp\u00e4\u00e4 M, Kujala I, Harjulahti E, Stenstr\u00f6m I, Nammas W, Knuuti J, et al. The impact of diabetes on the relationship of coronary artery disease and outcome: a study using multimodality imaging. Cardiovasc Diabetol. 2023. https:\/\/doi.org\/10.1186\/S12933-023-01850-3.","journal-title":"Cardiovasc Diabetol"},{"key":"3006_CR36","doi-asserted-by":"publisher","DOI":"10.1177\/1479164120941809","author":"C Gyldenkerne","year":"2020","unstructured":"Gyldenkerne C, Olesen KKW, Thrane PG, Madsen M, Thim T, W\u00fcrtz M, et al. Diabetes is not a risk factor for myocardial infarction in patients without coronary artery disease: a study from the Western Denmark Heart Registry. Diab Vasc Dis Res. 2020. https:\/\/doi.org\/10.1177\/1479164120941809.","journal-title":"Diab Vasc Dis Res"},{"key":"3006_CR37","doi-asserted-by":"publisher","unstructured":"Assante R, Mainolfi CG, Zampella E, Gaudieri V, Nappi C, Mannarino T, et al. Relation between myocardial blood flow and cardiac events in diabetic patients with suspected coronary artery disease and normal myocardial perfusion imaging. Journal of Nuclear Cardiology [Internet]. Springer; 2021 [cited 2025 May 25];28:1222\u201333. https:\/\/doi.org\/10.1007\/S12350-021-02533-W\/FIGURES\/3.","DOI":"10.1007\/S12350-021-02533-W\/FIGURES\/3"},{"key":"3006_CR38","doi-asserted-by":"publisher","unstructured":"Caobelli F, Haaf P, Haenny G, Pfisterer M, Zellweger MJ. Prognostic value of myocardial perfusion scintigraphy in asymptomatic patients with diabetes mellitus at high cardiovascular risk: 5-year follow-up of the prospective multicenter BARDOT trial. Eur J Nucl Med Mol Imaging [Internet]. Springer Science and Business Media Deutschland GmbH; 2021 [cited 2025 May 25];48:3512\u201321. https:\/\/doi.org\/10.1007\/S00259-021-05349-5\/FIGURES\/4.","DOI":"10.1007\/S00259-021-05349-5\/FIGURES\/4"},{"key":"3006_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/J.JCCT.2024.12.083","author":"ZM Gebert","year":"2025","unstructured":"Gebert ZM, Kwiecinski J, Weir-McCall JR, Adamson PD, Mills NL, Roditi G, et al. Impact of diabetes mellitus on coronary artery plaque characteristics and outcomes in the SCOT-HEART trial. J Cardiovasc Comput Tomogr. 2025. https:\/\/doi.org\/10.1016\/J.JCCT.2024.12.083.","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"2","key":"3006_CR40","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2337\/DC21-1663","volume":"46","author":"RA Jonas","year":"2023","unstructured":"Jonas RA, Crabtree TR, Jennings RS, Marques H, Katz RJ, Chang HJ, et al. Diabetes, atherosclerosis, and stenosis by AI. Diabetes Care. 2023;46(2):416\u201324. https:\/\/doi.org\/10.2337\/DC21-1663.","journal-title":"Diabetes Care"},{"key":"3006_CR41","doi-asserted-by":"publisher","unstructured":"Schulze K, Stantien AM, Williams MC, Vassiliou VS, Giannopoulos AA, Nieman K, et al. Coronary CT angiography evaluation with artificial intelligence for individualized medical treatment of atherosclerosis: a Consensus Statement from the QCI Study Group. Nature Reviews Cardiology 2025 [Internet]. Nature Publishing Group; 2025 [cited 2025 Oct 22];12:1\u201316. https:\/\/doi.org\/10.1038\/s41569-025-01191-6.","DOI":"10.1038\/s41569-025-01191-6"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03006-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-03006-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03006-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:04:45Z","timestamp":1764842685000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-03006-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3006"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-03006-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was investigator-initiated and complies with the Declaration of Helsinki. The ethics committees of the Hospital District of Southwest Finland and Amsterdam University Medical Center approved the study protocol and waived the need for informed consent due to the retrospective nature and observational study design.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. B\u00e4r received research grants to the institution from Medis Medical Imaging Systems, Bangerter-Rhyner Stiftung (Basel, Switzerland) and Abbott, outside the submitted work, speaker fees from Cleerly inc. and travel fees from Sanofi. Dr. Knuuti received consultancy fees from GE Healthcare and Synektik and speaker fees from Siemens, outside of the submitted work. Dr. Saraste received consultancy fees from Astra Zeneca and Pfizer, and speaker fees from Abbott, Astra Zeneca, Janssen, Novartis and Pfizer. Dr. Bax received speaker fees from Abbott. Dr. Danad is a member of Cleerly Scientific Advisory Board. Dr. Knaapen has received research grants from Cleerly, Inc. and HeartFlow. Dr. Sprengers receive speaker fees from Boehringer-Ingelheim, Ferrer, MSD and Siemens, outside of the submitted work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"453"}}